Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.0 | 0.0 | 18.2 |
| Revenue growth | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 36.3 |
| Gross profit | 0.0 | 0.0 | -18.2 |
| Gross margin | | | -100.0% |
| Research and development | 26.7 | 24.3 | |
| General and administrative | 10.2 | 4.6 | 2.8 |
| EBIT | -36.9 | -28.9 | -21.0 |
| EBIT margin | | | -115.5% |
| Pre-tax income | -36.9 | -28.3 | -20.8 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Net income | -42.9 | -35.0 | 0.0 |
| Net margin | | | -0.1% |
| |
| Diluted EPS | ($4.49) | ($24.16) | ($18.14) |
| Shares outstanding (diluted) | 9.6 | 1.5 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|